Polo-like kinase 1 inhibition in NSCLC: mechanism of action and emerging predictive biomarkers
Jan A Stratmann, Martin SebastianDepartment of Internal Medicine II, University Clinic of Frankfurt, 60596 Frankfurt, GermanyAbstract: Non-small cell lung cancer (NSCLC) is the leading cause of cancer death worldwide. Due to often unspecific disease symptoms, locally advanced or metastatic disease i...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2019-07-01
|
| Series: | Lung Cancer : Targets and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/polo-like-kinase-1-inhibition-in-nsclc-mechanism-of-action-and-emergin-peer-reviewed-article-LCTT |